Archrock Announces Timing for Second Quarter 2024 Results
July 24, 2024 16:05 ET
|
Archrock
HOUSTON, July 24, 2024 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE:AROC) (“Archrock”) will host a conference call on Wednesday, July 31, 2024, to discuss its second quarter 2024 financial and operating...
American Coastal Insurance Corporation Schedules Second Quarter 2024 Financial Results and Conference Call
July 24, 2024 16:05 ET
|
American Coastal
ST. PETERSBURG, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- American Coastal Insurance Corporation (Nasdaq Ticker: ACIC) (“the Company”, “American Coastal” or “ACIC”) the insurance holding company of...
Churchill Downs Incorporated Reveals Grandstand Club and Pavilion Renovation Plan for Churchill Downs Racetrack
July 24, 2024 16:05 ET
|
Churchill Downs Incorporated
LOUISVILLE, Ky., July 24, 2024 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “the Company”) announced today an $80-$90 million renovation to the existing grandstand at Churchill Downs...
Churchill Downs Incorporated Announces Robert L. Fealy Retires From Company’s Board of Directors
July 24, 2024 16:05 ET
|
Churchill Downs Incorporated
LOUISVILLE, Ky., July 24, 2024 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “Company”) announced today that Robert L. Fealy retired from CDI’s Board of Directors on July 23, 2024. ...
QCR Holdings, Inc. Announces Net Income of $29.1 Million for the Second Quarter of 2024
July 24, 2024 16:05 ET
|
QCR Holdings, Inc.
Second Quarter 2024 Highlights Net income of $29.1 million, or $1.72 per diluted shareNet interest income up $1.5 million, or nearly 3% from the prior quarter, an 11% annualized growth...
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 15, 2024
July 24, 2024 16:05 ET
|
Nasdaq, Inc.
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of July 15, 2024, short interest in 3,044 Nasdaq Global MarketSM securities totaled 12,309,469,231 shares compared with...
Psyence Biomed Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial
July 24, 2024 16:05 ET
|
Psyence Biomedical Ltd.
Trial projected to be initiated shortly following receipt of drug product by trial sites NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the...
Capital Product Partners L.P. Announces Cash Distribution
July 24, 2024 16:05 ET
|
Capital Product Partners, L.P.
ATHENS, Greece, July 24, 2024 (GLOBE NEWSWIRE) -- Capital Product Partners L.P. (NASDAQ: CPLP) today announced that its board of directors has declared a cash distribution of $0.15 per common unit...
TransCode Therapeutics, Inc. Announces Closing of Public Offering
July 24, 2024 16:05 ET
|
TransCode Therapeutics, Inc.
Boston, MA — July 24, 2024 — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to
Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference
July 24, 2024 16:05 ET
|
Clover Health Investments, Corp.
FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed...